TrueBlue Inc (TBI)


TrueBlue, Inc. is a common stock listing on the NYSE for a company that provides specialized workforce solutions across the United States, Canada, the United Kingdom, Australia, and Puerto Rico. Through its three operating segments—PeopleReady, PeopleManagement, and PeopleSolutions—the company serves a range of labor and talent needs. Its services include contingent staffing for general, industrial, and skilled trade roles; on-site industrial staffing and commercial driver solutions; and recruitment process outsourcing, talent advisory, and managed service provider offerings. TrueBlue also operates the Affinix platform to support sourcing, screening, and onboarding for permanent hiring. Founded in 1985 and based in Tacoma, Washington, the company was previously known as Labor Ready, Inc. before adopting the TrueBlue name in 2007.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-TBI
$9.86
18.2% Upside
Undervalued
$8.50
1.9% Upside
Fair
Weak
0.0%
July 27, 2026
-4.7x
1.0x
0.2x
260.6 M
359.9 M
33.4%
93.1%
4.1
111.5%
Valuation • Fair Value

TrueBlue Inc (NYSE-TBI) Fair Value by Valuation Model

Compare the primary fair value estimate for TrueBlue Inc (NYSE-TBI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$9.86

Estimated upside of 18.2% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$9.07

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$15.99

Earnings power value estimate.

Comps Fair Value

$9.62

Comparable-company valuation reference.

Analyst Price Target

$8.50

Analysts imply upside of 1.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for TrueBlue Inc (NYSE-TBI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for TrueBlue Inc (NYSE-TBI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.644 B

Current operating scale indicator.

Revenue Forecast

1.702 B

Forward revenue estimate.

EBITDA

-8.494 M

Current operating profitability reference.

EBITDA Forecast

26.367 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review TrueBlue Inc (NYSE-TBI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for TrueBlue Inc (NYSE-TBI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.43

No elevated caution signal from this screen.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

111.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for TrueBlue Inc (NYSE-TBI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for TrueBlue Inc (NYSE-TBI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 27, 2026

Days to Earnings

6

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for TrueBlue Inc (NYSE-TBI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

TrueBlue Inc (NYSE-TBI) Stock Forecast & Technical Outlook

Review TrueBlue Inc (NYSE-TBI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for TrueBlue Inc (NYSE-TBI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for TrueBlue Inc (NYSE-TBI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for TrueBlue Inc (NYSE-TBI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for TrueBlue Inc (NYSE-TBI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for TrueBlue Inc (NYSE-TBI) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for TrueBlue Inc (NYSE-TBI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, TrueBlue Inc (NYSE-TBI) has a Buy consensus, with 1 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 1
Sell 0
FAQ Fast Investor Answers

TrueBlue Inc (NYSE-TBI) Stock FAQ

Quick answers about TrueBlue Inc (NYSE-TBI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$9.86
Estimated upside 18.2%
Valuation Rating
Undervalued
Estimated upside of 18.2%
Analyst Target
$8.50
Implied upside 1.9%
Financial Health
Weak
Current financial-health read

The current fair value estimate for TrueBlue Inc (NYSE-TBI) is $9.86. This implies an estimated upside of 18.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 18.2% versus the current market price.

The available analyst price target for TrueBlue Inc (NYSE-TBI) is $8.50. The analyst target implies estimated upside of 1.9%.

The current financial health read for TrueBlue Inc (NYSE-TBI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for TrueBlue Inc (NYSE-TBI) is July 27, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for TrueBlue Inc (NYSE-TBI) is -4.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for TrueBlue Inc is 260.6 M.

The current enterprise value listed for TrueBlue Inc is 359.9 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for TrueBlue Inc is NYSE-TBI, and the stock is listed on NYSE.

TrueBlue Inc (NYSE-TBI) is listed on NYSE.

The current debt-to-total-capital ratio listed for TrueBlue Inc is 33.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for TrueBlue Inc is 93.1%. Free float helps investors understand how much of the share base is available for public trading.